The implant earned de novo clearance in late 2022 following an investigational device exemption study with the FDA, according to a March 30 press release.
Pyrocarbon has been used in orthopedics since the 1990s and was first used in shoulder applications in 2013, but Stryker is the first U.S. company to offer an FDA-cleared pyrocarbon implant for shoulder hemiarthroplasty.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
